Table of Content - Immuno Oncology Assays Market

Global immuno-oncology assays market is estimated to be valued at USD 4.98 Bn in 2024 and is expected to exhibit a CAGR of 11.2% during the forecast period (2024-2031). Immuno-oncology assays help analyze the expression of biomolecules like proteins that are relevant for cancer immunotherapies. These assays aid in tumor profiling, treatment strategies, and development of immunotherapies. They help evaluate expression of immune biomarkers, which provides crucial insights into cancer-immune interactions and offers direction for targeted therapies. Advancements in fields like proteomics, genomic analysis, and multiplex technologies have enabled development of high-throughput immuno-oncology assays. Their ability to gauge pre-existing antitumor immune responses and predict treatment outcomes makes them integral tools in precision oncology.

Market Dynamics:

The global immuno-oncology assays market growth is driven by factors such as growing demand for targeted cancer therapies, rising adoption of combinational immunotherapies, increasing R&D investments by pharmaceutical companies, and improving availability of companion diagnostic tests. However, the market faces restraints in terms of high costs associated with immuno-oncology assays and limited reimbursement for such tests. Meanwhile, ongoing research on biomarkers and development of affordable immuno-oncology assays present significant opportunities for market players.

Key Features of the Study:

This report provides an in-depth analysis of the global immuno-oncology assays market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global immuno-oncology assays market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Charles River Laboratories, F. Hoffmann-La Roche Ltd, llumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Invivoscribe, Inc., QIAGEN, PerkinElmer Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Bruker Spatial Biology, Inc., Nexelis, Reaction Biology, Crown Bioscience, HTG Molecular Diagnostics, Inc., Axion BioSystems, Inc, and BioTherapeutics LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global immuno-oncology assays market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market

Detailed Segmentation-

By Product:
- Consumables
- Software
By Technology:
- Immunoassay
- PCR
- NGS
- Fow Cytometry
- Others
By Indication:
- Colorectal Cancer
- Lung Cancer
- Melanoma
- Bladder Cancer
- Others
By Application:
- Clinical Diagnostics
- Research and Development
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Charles River Laboratories
- Hoffmann-La Roche Ltd
- llumina, Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Invivoscribe, Inc.
- QIAGEN
- PerkinElmer Inc.
- Sartorius AG
- Bio-Rad Laboratories, Inc.
- Bruker Spatial Biology, Inc.
- Nexelis
- Reaction Biology
- Crown Bioscience
- HTG Molecular Diagnostics, Inc.
- Axion BioSystems, Inc
- BioTherapeutics LLC

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Product
  - Market Snapshot, By Technology
  - Market Snapshot, By Indication
  - Market Snapshot, By Application
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Immuno-Oncology Assays Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
Global Immuno-Oncology Assays Market, By Product, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Consumables
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Software
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Immuno-Oncology Assays Market, By Technology, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Immunoassay
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- PCR
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- NGS
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Fow Cytometry
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Immuno-Oncology Assays Market, By Indication, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Colorectal Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Lung Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Melanoma
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Bladder Cancer
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Immuno-Oncology Assays Market, By Application, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2020 – 2031
  - Segment Trends
- Clinical Diagnostics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Research and Development
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Immuno-Oncology Assays Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2020–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Charles River Laboratories*
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - F. Hoffmann-La Roche Ltd
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - llumina, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Agilent Technologies, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Thermo Fisher Scientific Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Merck KGaA
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Invivoscribe, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - QIAGEN
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - PerkinElmer Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sartorius AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bio-Rad Laboratories, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bruker Spatial Biology, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Nexelis
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Reaction Biology
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Crown Bioscience
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - HTG Molecular Diagnostics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Axion BioSystems, Inc
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - BioTherapeutics LLC
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendation
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact

*Browse 32 market data tables and 29 figures on "Immuno-Oncology Assays Market” - Global forecast to 2031

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE